跳至主要内容
临床试验/NCT04351542
NCT04351542已完成不适用

Ayurveda for Flu-like Illness During the Covid 19 Outbreak: Non Randomised Single-blind Controlled Trial

Aarogyam UK1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2020年3月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
32
试验地点
1
主要终点
Severity of symptom score

研究概览

简要总结

This study aimed to evaluate the efficacy and safety of Ayurveda in reducing symptoms of flu like illness during the Covid 19 outbreak.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Care Provider)

盲法说明

Ayurveda care provide was blinded

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with fu like symptoms within 48 hours of onset during March2020
  • Mild to moderate symptoms who were advised to self isolate at home for 7-14 days
  • Flu like symptoms present at least one respiratory symptom (e.g. cough, nasal obstruction, sore throat) and at least one constitutional symptom other than fever (e.g. fatigue, headache, myalgias) of less than 48-hour duration
  • Willing to consent and follow up

排除标准

  • Pregnant/lactating
  • Participants with chronic pulmonary diseases or critical condition or already developed severe respiratory distress
  • Clinically malignancies, systemic infection, other medical or psychiatric condition which places the subject at unacceptable risk to participate in the study - Known hypersensitivity to any ayurveda herbal substances
  • Severe symptoms of respiratory distress patients deemed to require intensive care immediately

结局指标

主要结局

Severity of symptom score

时间窗: Change from baseline to 3rd and 7th day

Symptoms diary card completed twice daily from Day 0 to Day 7

Time to achieve afebrile

时间窗: Change from baseline to 3rd and 7th-day

Time to bring down a fever (oral temperature \< 37.2 ̊C)

次要结局

  • Patient reported improvement(Change from baseline to 3rd and 7th-day)

研究者

发起方
Aarogyam UK
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验